Sort
130,381 grants matching “hiv”
LC - IMPAACT Leadership Group
$2,823,246Grace M. Aldrovandi · Children'S Hospital Of Los Angeles · UM1 · FY2015 · AI
Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV)
$2,823,243Casey Koontz · · N01 · FY2015 · AI
Women's Interagency HIV Study (WIHS) III
$2,822,756Howard Minkoff · Suny Downstate Medical Center · U01 · FY2007 · AI
Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention
$2,820,494Robert Rodick · Vxbiosciences, Inc. · R01 · FY2021 · AI
Southern California Women's Interagency HIV Study Consortium
$2,819,748Marek Jan Nowicki · University Of Southern California · U01 · FY2011 · HD
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$2,819,529Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2017 · AI
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,819,169Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
HIV Database and Analysis Unit
$2,818,637National Institute Of Allergy And Infectious Diseases · Y01 · FY2025 · AI
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,818,392Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,817,027Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2024 · HL
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$2,816,120Deborah Joy Sennett · Mississippi State Department Of Health · U62 · FY2012 · PS
Epitope-targeted Vaccines for HIV-1 Prevention
$2,816,030Xiangpeng Kong · New York University School Of Medicine · P01 · FY2015 · AI
NHGRI/DIR Bioinformatics and Scientific Programming Core
$2,815,914Andreas Baxevanis · National Human Genome Research Institute · ZIH · FY2011 · HG
Biology of Mammalian Base Excision Repair and HIV-1 Replication
$2,815,825Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities
$2,814,849Michele D Kipke · Children'S Hospital Of Los Angeles · U01 · FY2021 · DA
The Johns Hopkins University-Blantyre Clinical Trials Unit
$2,814,014Taha E Taha · Johns Hopkins University · UM1 · FY2022 · AI
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,813,254Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2023 · HL
SUPPORTING TANZANIA TO EXPAND, STRENGTHEN & SUBSTAIN HIGH QUALITY HIV COUNSELING
$2,812,882James McMahan · Intrahealth International, Inc. · U2G · FY2013 · GH
TECHNICAL ASSISTANCE TO THE MOH FOR HIV SVC & PROGRAM TRANSITION (PEPFAR)
$2,812,139Wafaa M. El-Sadr · Columbia University Health Sciences · U2G · FY2011 · GH
Mucosal Discovery Team
$2,811,879Thomas N Denny · Duke University · U19 · FY2011 · AI
High Resolution Analysis of Env-directed B Cells to Accelerate Vaccine Design
$2,810,461Richard Thomas Wyatt · Scripps Research Institute, The · P01 · FY2015 · AI
HIV TREATMENT FOR RESEARCH SUBJECTS OR BY RESEARCHERS IN KENYA
$2,810,000Elizabeth Maleche Obimbo · University Of Nairobi · U62 · FY2009 · PS
Alternative Formulations of Tenofovir and UC781
$2,809,788Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2011 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$2,809,785Deborah Joy Sennett · Mississippi State Department Of Health · U62 · FY2014 · PS
Characterizing HIV latent reservoir in vivo
$2,809,013Shomyseh Sanjabi · J. David Gladstone Institutes · DP2 · FY2013 · AI